Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis.

Kangho SuhBrian J ColeAndreas GomollSeung-Mi LeeHangseok ChoiChul-Won HaHong Chul LimMyung Ku KimGwi-Yeom HaDong-Churl Suh

Published in: Applied health economics and health policy (2022)

The study demonstrated that hUCB-MSC therapy was cost effective compared with microfracture when treating patients with knee OA. These findings should inform health policy decision makers about considerations for cost-effective therapy for treating knee OA to ultimately enhance population health.

Keyphrases

knee osteoarthritis
umbilical cord
mesenchymal stem cells
public health
healthcare
mental health
stem cell transplantation
bone marrow
total knee arthroplasty
health information
decision making
low dose
risk assessment
climate change